Our team has the experience and resources to help analyze your PET opportunity and ensure a successful transition as you add cardiac PET and PET/CT to your patient management options.
As industry experts, we are focused on the clinical advantages of PET and PET/CT today, while preparing for new isotopes in the developmental pipeline.